55.25
前日終値:
$53.95
開ける:
$54.42
24時間の取引高:
14.21M
Relative Volume:
0.49
時価総額:
$12.04B
収益:
$1.78B
当期純損益:
$164.40M
株価収益率:
80.07
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
+0.99%
1か月 パフォーマンス:
-0.36%
6か月 パフォーマンス:
+103.08%
1年 パフォーマンス:
+195.88%
Hims Hers Health Inc Stock (HIMS) Company Profile
HIMS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HIMS
Hims Hers Health Inc
|
55.31 | 12.19B | 1.78B | 164.40M | 236.51M | 0.69 |
![]()
ZTS
Zoetis Inc
|
142.29 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.74 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.065 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.13 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
440.82 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-23 | ダウングレード | Needham | Buy → Hold |
2025-06-04 | 繰り返されました | Needham | Buy |
2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
2025-01-07 | 開始されました | BTIG Research | Buy |
2024-12-17 | 開始されました | Morgan Stanley | Overweight |
2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
2024-08-22 | 開始されました | Needham | Buy |
2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
2024-04-10 | 開始されました | Canaccord Genuity | Buy |
2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
2024-02-26 | 開始されました | Leerink Partners | Market Perform |
2023-12-07 | 開始されました | Imperial Capital | In-line |
2023-07-28 | 開始されました | TD Cowen | Outperform |
2023-04-11 | 開始されました | Robert W. Baird | Neutral |
2023-02-09 | アップグレード | Jefferies | Hold → Buy |
2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-09-07 | 開始されました | Truist | Hold |
2022-07-15 | 開始されました | SVB Leerink | Underperform |
2022-04-14 | 開始されました | Guggenheim | Buy |
2022-04-01 | 再開されました | Credit Suisse | Outperform |
2022-03-10 | 開始されました | Deutsche Bank | Hold |
2021-12-02 | 開始されました | Jefferies | Hold |
2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-07-06 | 開始されました | BofA Securities | Neutral |
2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
2021-04-21 | 開始されました | Truist | Hold |
2021-03-09 | 開始されました | Credit Suisse | Neutral |
2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
2021-02-17 | 開始されました | Citigroup | Neutral |
2021-02-12 | 開始されました | Piper Sandler | Neutral |
2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Best Healthcare Stocks To Keep An Eye OnOctober 12th - MarketBeat
Callan Family Office LLC Grows Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Top Healthcare Stocks To Watch NowOctober 11th - MarketBeat
SLT Holdings LLC Purchases Shares of 8,125 Hims & Hers Health, Inc. $HIMS - MarketBeat
Total Wealth Planning & Management Inc. Makes New $593,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Why Hims & Hers Health (HIMS) Stock Is Nosediving - The Globe and Mail
Moderate Bearish Sentiment Surrounds HIMS as Options Activity Su - GuruFocus
Option traders moderately bearish in Hims and Hers Health with shares down 5.36% - TipRanks
Healthcare Stocks To Add to Your WatchlistOctober 10th - MarketBeat
HIMS: BofA Sees Revenue Challenges Ahead - GuruFocus
Hims and Hers stock price target maintained at $28 by BofA amid weak order trends - Investing.com
Promising Healthcare Stocks Worth WatchingOctober 9th - MarketBeat
How Hims & Hers founder Joe Spector turned 10 failures into $1B idea - Yahoo Finance
Hims & Hers Expands Personalized Care Access Via Telehealth Platform - TradingView
Hims & Hers survey: 94% of customers rate telehealth care equal to in-person - Investing.com Canada
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Hims Investor Relations
Abel Hall LLC Purchases Shares of 4,993 Hims & Hers Health, Inc. $HIMS - MarketBeat
Robeco Institutional Asset Management B.V. Trims Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Is Hims & Hers Health Still Attractive After FDA Scrutiny Over Super Bowl Ad? - Yahoo Finance
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives - MSN
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships - Seeking Alpha
Will Hims’ (HIMS) Leadership Shift Reveal New Strengths in Operational Execution? - Yahoo
10 Hot Stocks Sparking Buying Frenzy - Insider Monkey
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 11,595 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading 5.8% HigherHere's What Happened - MarketBeat
Hims & Hers CFO Okupe sells $669k in shares - Investing.com
Best Healthcare Stocks To Follow NowOctober 7th - MarketBeat
Hims & Hers: Are New Health Products Boosting Stocks? - StocksToTrade
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts? - TipRanks
111 Capital Sells 6,970 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Shares Sold by QRG Capital Management Inc. - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Recent Price Surge - Quiver Quantitative
Why Hims & Hers Stock Slipped Today - MSN
HIMS Stock Dips Following Executive Transition Announcement - GuruFocus
U.S. Indexes Ended Friday Mixed As Rigetti Computing Led, Hims & Hers Health Lagged - Barron's
$HIMS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Weatherford Democrat
Hims & Hers Expands Health Access Through Subscription Revenue Model - Yahoo Finance
Evaluating Hims & Hers Health (HIMS) Valuation After 39% Share Price Surge in the Past Month - Yahoo Finance
Matauro LLC Invests $446,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (NYSE:HIMS) Stock Price Down 5.4%Time to Sell? - MarketBeat
Hims & Hers Health names new COO - Seeking Alpha
Hims & Hers Health Announces COO Transition - TipRanks
Hims & Hers Health says Nader Kabbani to step into advisory role on November 2SEC filing - MarketScreener
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - MSN
How Novo Nordisk Gave Up Its Weight-Loss Gains - Bloomberg.com
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
Hims Hers Health Inc (HIMS) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Okupe Oluyemi | Chief Financial Officer |
Oct 03 '25 |
Option Exercise |
7.15 |
11,595 |
82,919 |
81,827 |
Okupe Oluyemi | Chief Financial Officer |
Oct 03 '25 |
Sale |
57.72 |
11,595 |
669,232 |
70,232 |
Chi Michael | Chief Commercial Officer |
Oct 01 '25 |
Option Exercise |
11.53 |
250 |
2,882 |
291,689 |
Chi Michael | Chief Commercial Officer |
Oct 01 '25 |
Sale |
56.00 |
250 |
14,000 |
291,439 |
大文字化:
|
ボリューム (24 時間):